The role of tumor stroma in the interaction between tumor and immune system
Data up to Jan 2025
Total Citations Per Year
Abstract
References (59)
The Hallmarks of Cancer
2000 • 27,569 citations
Inflammation and cancer
2002 • 14,174 citations
Inflammation. Basic principles and clinical correlates
1989 • 2,424 citations
Putting tumours in context
2001 • 2,145 citations
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
2001 • 1,556 citations
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
2000 • 1,445 citations
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
2004 • 1,346 citations
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
2003 • 919 citations
Stromal Effects on Mammary Gland Development and Breast Cancer
2002 • 902 citations
Murine interleukin-4 displays potent anti-tumor activity in vivo
1989 • 790 citations
Inflammation: Basic Principles and Clinical Correlates
2000 • 616 citations
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001 • 554 citations
CD4 + T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells
2000 • 505 citations
Decreased tumor surveillance in perforin-deficient mice.
1996 • 487 citations
Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
1999 • 445 citations
Know thy neighbor: stromal cells can contribute oncogenic signals
2001 • 422 citations
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.
1990 • 417 citations
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.
1991 • 402 citations
Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.
1984 • 366 citations
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 • 307 citations
Bystander elimination of antigen loss variants in established tumors
2004 • 259 citations
Inhibition of Angiogenesis by Interleukin 4
1998 • 254 citations
Increasing Tumor Antigen Expression Overcomes “Ignorance” to Solid Tumors via Crosspresentation by Bone Marrow-Derived Stromal Cells
2002 • 239 citations
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
2003 • 229 citations
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.
2003 • 227 citations
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.
1993 • 221 citations
Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.
1994 • 188 citations
Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay
2001 • 152 citations
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
1996 • 151 citations
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
2001 • 147 citations
Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts
1993 • 146 citations
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.
1993 • 140 citations
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy
2001 • 130 citations
Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin
2002 • 128 citations
CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction
2004 • 126 citations
The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis
2003 • 121 citations
Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts
2002 • 107 citations
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy
2001 • 106 citations
Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent
2004 • 91 citations
Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor
2000 • 84 citations
Tumor Regression After Adoptive Transfer of Effector T Cells Is Independent of Perforin or Fas Ligand (APO-1L/CD95L)
1999 • 82 citations
Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells
2003 • 78 citations
TNF Plays an Essential Role in Tumor Regression after Adoptive Transfer of Perforin/IFN-γ Double Knockout Effector T Cells
2003 • 77 citations
A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL
2004 • 74 citations
Tumor Necrosis Factor Induces Tumor Necrosis via Tumor Necrosis Factor Receptor Type 1-Expressing Endothelial Cells of the Tumor Vasculature
2000 • 67 citations
The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium
1997 • 54 citations
Differential requirement of perforin and IFN-γ in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen
2000 • 51 citations
Immunotherapy of Melanoma: A Dichotomy in the Requirement for IFN-γ in Vaccine-Induced Antitumor Immunity Versus Adoptive Immunotherapy
2001 • 51 citations
Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.
1998 • 50 citations
T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics
2000 • 47 citations
Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection
2001 • 46 citations
The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis
2004 • 42 citations
Tumor Rejection by Modulation of Tumor Stromal Fibroblasts
2003 • 39 citations
Characterizing the Protective Component of the αβ T Cell Response to Transplantable Squamous Cell Carcinoma
2004 • 37 citations
Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance
2003 • 35 citations
Long-Term Suppression of Tumor Growth by TNF Requires a Stat1- and IFN Regulatory Factor 1-Dependent IFN-γ Pathway but Not IL-12 or IL-18
2004 • 26 citations
Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack
2003 • 22 citations
Response to 'A cancer immunosurveillance controversy'
2003 • 15 citations
Observations with tumour necrosis factor gene-transfected tumours.
1994 • 6 citations